Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Cardiovascular Safety of Gonadotropin-releasing Hormone Antagonists and Agonists Among Patients Diagnosed with Prostate Cancer: A Systematic Review and Meta-analysis of Real-world Evidence Studies.
Patel S, Zhu K, Dave CV, Ghajar M, Zhang Y, Saraiya B, Bandera EV, Khosrow-Khavar F. Patel S, et al. Among authors: bandera ev. Eur Urol Oncol. 2024 Sep 28:S2588-9311(24)00213-X. doi: 10.1016/j.euo.2024.09.004. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39343637 Free article. Review.
A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States.
Cullen MR, Lemeshow AR, Amaro S, Bandera EV, Cooper LA, Kawachi I, Lunyera J, McKinley L, Poss CS, Rottas MM, Schachterle SE, Thadeio PF, Russo LJ. Cullen MR, et al. Among authors: bandera ev. Contemp Clin Trials. 2023 Jun;129:107184. doi: 10.1016/j.cct.2023.107184. Epub 2023 Apr 11. Contemp Clin Trials. 2023. PMID: 37054773 Free article.
Diet and Survival in Black Women With Epithelial Ovarian Cancer.
Armidie TA, Bandera EV, Johnson CE, Peres LC, Haller K, Terry P, Akonde M, Peters ES, Cote ML, Hastert TA, Collin LJ, Epstein M, Marks J, Bondy M, Lawson AB, Alberg AJ, Schildkraut JM, Qin B. Armidie TA, et al. Among authors: bandera ev. JAMA Netw Open. 2024 Oct 1;7(10):e2440279. doi: 10.1001/jamanetworkopen.2024.40279. JAMA Netw Open. 2024. PMID: 39422908 Free article.
The role of multiple mediation with contextual neighborhood measures in ovarian cancer survival.
Lawson AB, Xin Y, Peters ES, Johnson C, Hastert T, Bandera EV, Alberg AJ, Collin L, Terry P, Akonde M, Mandle H, Cote ML, Bondy M, Marks J, Peres LC, Ratnapradipa KL, Schildkraut JM. Lawson AB, et al. Among authors: bandera ev. Ann Epidemiol. 2024 Nov;99:41-46. doi: 10.1016/j.annepidem.2024.10.002. Epub 2024 Oct 9. Ann Epidemiol. 2024. PMID: 39389398
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: bandera ev. Breast Cancer Res Treat. 2024 Nov;208(2):405-414. doi: 10.1007/s10549-024-07433-4. Epub 2024 Aug 16. Breast Cancer Res Treat. 2024. PMID: 39150586
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature.
Hurson AN, Ahearn TU, Koka H, Jenkins BD, Harris AR, Roberts S, Fan S, Franklin J, Butera G, Keeman R, Jung AY, Middha P, Gierach GL, Yang XR, Chang-Claude J, Tamimi RM, Troester MA, Bandera EV, Abubakar M, Schmidt MK, Garcia-Closas M. Hurson AN, et al. Among authors: bandera ev. medRxiv [Preprint]. 2024 Mar 19:2024.03.18.24304210. doi: 10.1101/2024.03.18.24304210. medRxiv. 2024. Update in: J Natl Cancer Inst. 2024 Jul 17:djae172. doi: 10.1093/jnci/djae172. PMID: 39108508 Free PMC article. Updated. Preprint.
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: bandera ev. Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1286-1297. doi: 10.1158/1055-9965.EPI-24-0360. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39051907
365 results